Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A JELLINEK

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Biochemical Journal|August 19, 2000
Stanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cellsD A Jellinek, A C Chang, M R Larsen, et al.
British Journal of Cancer|June 17, 2004
DNA replication licensing and cell cycle kinetics of oligodendroglial tumoursS B Wharton, S Hibberd, K L Eward, et al.
Acta Neuropathologica|December 13, 2006
Subtypes of oligodendroglioma defined by 1p,19q deletions, differ in the proportion of apoptotic cells but not in replication-licensed non-proliferating cellsS B Wharton, E Maltby, D A Jellinek, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 13, 2001
Detection of subarachnoid haemorrhage with magnetic resonance imagingP Mitchell, I D Wilkinson, N Hoggard, et al.
Lancet (London, England)|March 19, 2003
Alternative lengthening of telomeres and survival in patients with glioblastoma multiformeV Hakin-Smith, D A Jellinek, D Levy, et al.
Cancer Research|July 5, 2006
Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in gliomaYu-Jen Chen, Vicky Hakin-Smith, Mario Teo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomasJeremy D Henson, Jonathan A Hannay, Stanley W McCarthy, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Biochemical Journal|August 19, 2000
Stanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cellsD A Jellinek, A C Chang, M R Larsen, et al.
British Journal of Cancer|June 17, 2004
DNA replication licensing and cell cycle kinetics of oligodendroglial tumoursS B Wharton, S Hibberd, K L Eward, et al.
Acta Neuropathologica|December 13, 2006
Subtypes of oligodendroglioma defined by 1p,19q deletions, differ in the proportion of apoptotic cells but not in replication-licensed non-proliferating cellsS B Wharton, E Maltby, D A Jellinek, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 13, 2001
Detection of subarachnoid haemorrhage with magnetic resonance imagingP Mitchell, I D Wilkinson, N Hoggard, et al.
Lancet (London, England)|March 19, 2003
Alternative lengthening of telomeres and survival in patients with glioblastoma multiformeV Hakin-Smith, D A Jellinek, D Levy, et al.
Cancer Research|July 5, 2006
Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in gliomaYu-Jen Chen, Vicky Hakin-Smith, Mario Teo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomasJeremy D Henson, Jonathan A Hannay, Stanley W McCarthy, et al.
Pageof 2